Payer+Provider's Health System Review
A $2B delay — What ASCs, hospitals are missing out on when shutting down joint replacement programs
Eli Lilly drug first in series to be studied as coronavirus treatment by NIH
August 6, 2020
Read the full post on Becker's ASC Review
